Literature DB >> 28759036

Deficiency in VHR/DUSP3, a suppressor of focal adhesion kinase, reveals its role in regulating cell adhesion and migration.

Y-R Chen1, H-C Chou1, C-H Yang1, H-Y Chen1,2, Y-W Liu1, T-Y Lin1, C-L Yeh1, W-T Chao2, H-H Tsou3,4, H-C Chuang5, T-H Tan5,6.   

Abstract

Vaccinia H1-related phosphatase (VHR/DUSP3) is a member of the dual-specificity phosphatase family. Deregulation of VHR is observed in various malignant diseases. We identified focal adhesion kinase (FAK) as a VHR-interacting molecule. Over-expression of VHR decreased tyrosine phosphorylation of FAK and decreasing VHR promoted FAK tyrosine phosphorylation. In vitro assays proved that recombinant VHR directly dephosphorylated FAK and paxillin. VHR-knockout mice did not have obvious abnormality; however, VHR-knockout cells showed decreased expression of integrins and FAK but stronger FAK and paxillin phosphorylation upon attachment to fibronectin. Additionally, VHR-knockout fibroblast and lung epithelial cells had elevated ligand-induced epidermal growth factor receptor (EGFR) phosphorylation. Inducible expression of VHR suppressed directional cell migration, and VHR deficiency resulted in a higher cell migratory ability. VHR-knockout cells have stronger FAK phosphorylation in cell adhesions, long-lasting trailing ends and slower turnover of focal adhesions. These collective data indicate that VHR is a FAK phosphatase and participates in regulating the formation and disassembly of focal adhesions.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28759036     DOI: 10.1038/onc.2017.255

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  40 in total

1.  Identification and characterization of two novel low-molecular-weight dual specificity phosphatases.

Authors:  Kristin L Hood; James F Tobin; Christina Yoon
Journal:  Biochem Biophys Res Commun       Date:  2002-11-08       Impact factor: 3.575

2.  Dual-specificity protein tyrosine phosphatase VHR down-regulates c-Jun N-terminal kinase (JNK).

Authors:  Jacob L Todd; Johanna D Rigas; Louise A Rafty; John M Denu
Journal:  Oncogene       Date:  2002-04-11       Impact factor: 9.867

3.  Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src.

Authors:  M D Schaller; J D Hildebrand; J D Shannon; J W Fox; R R Vines; J T Parsons
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

4.  Down-regulation of B cell receptor signaling by hematopoietic progenitor kinase 1 (HPK1)-mediated phosphorylation and ubiquitination of activated B cell linker protein (BLNK).

Authors:  Xiaohong Wang; Ju-Pi Li; Hui-Kai Kuo; Li-Li Chiu; Gregory A Dement; Joung-Liang Lan; Der-Yuan Chen; Chia-Yu Yang; Hongbo Hu; Tse-Hua Tan
Journal:  J Biol Chem       Date:  2012-02-10       Impact factor: 5.157

5.  The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer.

Authors:  Yke Jildouw Arnoldussen; Petra I Lorenzo; Maria E Pretorius; Håkon Waehre; Bjørn Risberg; Gunhild M Maelandsmo; Håvard E Danielsen; Fahri Saatcioglu
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

6.  Specificity profiling of protein phosphatases toward phosphoseryl and phosphothreonyl peptides.

Authors:  Qing Xiao; Rinrada Luechapanichkul; Yujing Zhai; Dehua Pei
Journal:  J Am Chem Soc       Date:  2013-06-20       Impact factor: 15.419

7.  Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases.

Authors:  M B Calalb; T R Polte; S K Hanks
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

8.  Dual-specificity phosphatase 3 deficiency or inhibition limits platelet activation and arterial thrombosis.

Authors:  Lucia Musumeci; Marijke J Kuijpers; Karen Gilio; Alexandre Hego; Emilie Théâtre; Lisbeth Maurissen; Maud Vandereyken; Catia V Diogo; Christelle Lecut; William Guilmain; Ekaterina V Bobkova; Johannes A Eble; Russell Dahl; Pierre Drion; Justin Rascon; Yalda Mostofi; Hongbin Yuan; Eduard Sergienko; Thomas D Y Chung; Marc Thiry; Yotis Senis; Michel Moutschen; Tomas Mustelin; Patrizio Lancellotti; Johan W M Heemskerk; Lutz Tautz; Cécile Oury; Souad Rahmouni
Journal:  Circulation       Date:  2014-12-17       Impact factor: 29.690

9.  DUSPs, to MAP kinases and beyond.

Authors:  Ching-Yu Huang; Tse-Hua Tan
Journal:  Cell Biosci       Date:  2012-07-09       Impact factor: 7.133

10.  Blockade of dual-specificity phosphatase 28 decreases chemo-resistance and migration in human pancreatic cancer cells.

Authors:  Jungwhoi Lee; Jeong Hun Yun; Jungsul Lee; Chulhee Choi; Jae Hoon Kim
Journal:  Sci Rep       Date:  2015-07-27       Impact factor: 4.379

View more
  12 in total

1.  Transcriptome stability profiling using 5'-bromouridine IP chase (BRIC-seq) identifies novel and functional microRNA targets in human melanoma cells.

Authors:  Piyush Joshi; Tatsuya Seki; Shinobu Kitamura; Andrea Bergano; Bongyong Lee; Ranjan J Perera
Journal:  RNA Biol       Date:  2019-06-16       Impact factor: 4.652

2.  DUSP3 maintains genomic stability and cell proliferation by modulating NER pathway and cell cycle regulatory proteins.

Authors:  Lilian Cristina Russo; Jessica Oliveira Farias; Fabio Luis Forti
Journal:  Cell Cycle       Date:  2020-05-07       Impact factor: 4.534

3.  A Crosstalk Between Dual-Specific Phosphatases and Dual-Specific Protein Kinases Can Be A Potential Therapeutic Target for Anti-cancer Therapy.

Authors:  Basak Celtikci
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  DUSP11 Attenuates Lipopolysaccharide-Induced Macrophage Activation by Targeting TAK1.

Authors:  Chia-Yu Yang; Huai-Chia Chuang; Ching-Yi Tsai; Yu-Zhi Xiao; Jhih-Yu Yang; Rou-Huei Huang; Ying-Chun Shih; Tse-Hua Tan
Journal:  J Immunol       Date:  2020-08-12       Impact factor: 5.422

5.  Induction of DUSP14 ubiquitination by PRMT5-mediated arginine methylation.

Authors:  Chia-Yu Yang; Li-Li Chiu; Chih-Chi Chang; Huai-Chia Chuang; Tse-Hua Tan
Journal:  FASEB J       Date:  2018-06-19       Impact factor: 5.191

Review 6.  MAP4K Family Kinases and DUSP Family Phosphatases in T-Cell Signaling and Systemic Lupus Erythematosus.

Authors:  Huai-Chia Chuang; Tse-Hua Tan
Journal:  Cells       Date:  2019-11-13       Impact factor: 6.600

7.  DUSP6 protects murine podocytes from high glucose‑induced inflammation and apoptosis.

Authors:  Liqiang Chen; Yaokun Wang; Haiyan Luan; Guangyu Ma; Huiming Zhang; Guang Chen
Journal:  Mol Med Rep       Date:  2020-07-09       Impact factor: 2.952

8.  UV Radiation-induced Impairment of Cellular Morphology and Motility is Enhanced by DUSP3/VHR Loss and FAK Activation.

Authors:  Nadine Ranieri Pereira; Lilian Cristina Russo; Fabio Luis Forti
Journal:  Cell Biochem Biophys       Date:  2021-01-21       Impact factor: 2.194

9.  Dusp3 deletion in mice promotes experimental lung tumour metastasis in a macrophage dependent manner.

Authors:  Maud Vandereyken; Sophie Jacques; Eva Van Overmeire; Mathieu Amand; Natacha Rocks; Céline Delierneux; Pratibha Singh; Maneesh Singh; Camille Ghuysen; Caroline Wathieu; Tinatin Zurashvili; Nor Eddine Sounni; Michel Moutschen; Christine Gilles; Cécile Oury; Didier Cataldo; Jo A Van Ginderachter; Souad Rahmouni
Journal:  PLoS One       Date:  2017-10-11       Impact factor: 3.240

Review 10.  Revisiting the roles of VHR/DUSP3 phosphatase in human diseases.

Authors:  Lilian Cristina Russo; Jéssica Oliveira Farias; Pault Yeison Minaya Ferruzo; Lucas Falcão Monteiro; Fábio Luís Forti
Journal:  Clinics (Sao Paulo)       Date:  2018-09-06       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.